Andreas Wicki serves as Executive at Pacira Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Andreas Wicki has executed 118 insider transactions totaling $289.1M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 9, 2018 involved selling 906 shares valued at $45.5K.
Andreas Wicki currently holds 2,147,943 shares of Pacira Pharmaceuticals, Inc. (PCRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andreas Wicki has been a net seller of PCRX stock. They have purchased $15.2M and sold $273.9M worth of shares.
Andreas Wicki's most recent insider trade was on Nov 9, 2018, when they sold 906 shares at $50.23 per share.
Get notified when new Form 4 filings are submitted
| $51.13 |
| Discretionary |
| Aug 29, 2014 | PCRX | $1.1M | Sale | 10,481 | $108.15 | Discretionary |
| Aug 28, 2014 | PCRX | $1.2M | Sale | 11,013 | $108.06 | Discretionary |
| Aug 27, 2014 | PCRX | $173.5K | Sale | 1,606 | $108.05 | Discretionary |
| Aug 26, 2014 | PCRX | $2.6M | Sale | 24,207 | $108.11 | Discretionary |
| Aug 25, 2014 | PCRX | $3.2M | Sale | 30,000 | $108.07 | Discretionary |
| Aug 11, 2014 | PCRX | $3.8M | Sale | 37,786 | $101.82 | Discretionary |
| Aug 11, 2014 | PCRX | $3.0M | Sale | 30,114 | $101.20 | Discretionary |
| Aug 8, 2014 | PCRX | $8.3M | Sale | 82,100 | $101.00 | Discretionary |
| Jun 9, 2014 | PCRX | $2.1M | Sale | 25,058 | $84.55 | Discretionary |
| Jun 9, 2014 | PCRX | $802.8K | Sale | 9,289 | $86.43 | Discretionary |
| Jun 9, 2014 | PCRX | $2.9M | Sale | 33,653 | $85.81 | Discretionary |
| Jun 6, 2014 | PCRX | $3.3M | Sale | 40,200 | $82.71 | Discretionary |
| Jun 5, 2014 | PCRX | $1.9M | Sale | 23,200 | $82.53 | Discretionary |
| Jun 4, 2014 | PCRX | $370.8K | Sale | 4,500 | $82.40 | Discretionary |
| Jun 3, 2014 | PCRX | $4.6M | Sale | 57,400 | $80.72 | Discretionary |
| Jun 2, 2014 | PCRX | $853.5K | Sale | 10,600 | $80.52 | Discretionary |
| May 27, 2014 | PCRX | $5.0M | Sale | 64,400 | $77.93 | Discretionary |
| May 21, 2014 | PCRX | $280.1K | Sale | 3,600 | $77.80 | Discretionary |
| May 8, 2014 | PCRX | $1.8M | Sale | 23,220 | $75.76 | Discretionary |
| May 7, 2014 | PCRX | $45.4K | Sale | 600 | $75.64 | Discretionary |
| May 6, 2014 | PCRX | $3.3M | Sale | 44,180 | $75.78 | Discretionary |
| Mar 6, 2014 | PCRX | $176.2K | Sale | 2,200 | $80.11 | Discretionary |
| Mar 5, 2014 | PCRX | $1.8M | Sale | 22,687 | $80.16 | Discretionary |
| Sep 11, 2013 | PCRX | $100.1K | Sale | 2,686 | $37.25 | Discretionary |
| Sep 11, 2013 | PCRX | $562.3K | Exercise | 41,841 | $13.44 | Discretionary |
| Sep 11, 2013 | PCRX | $562.4K | Sale | 15,097 | $37.25 | Discretionary |
| Sep 11, 2013 | PCRX | $100.0K | Exercise | 37,192 | $2.69 | Discretionary |
| Jul 22, 2013 | PCRX | $703.4K | Sale | 19,938 | $35.28 | Discretionary |